SCHEMBL20735211

SCHEMBL20735211

COc1ccc(NC(=O)Nc2cccc(C)c2)cc1-c1c(Br)cnn1C

nearest known ligand 0.80

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 20/20 0.80
HTR2C P28335 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19413127 0.91 HTR2A (0.86) HTR2AHTR2C
SCHEMBL29573693 0.90 HTR2A (0.83) HTR2AHTR2C
SCHEMBL5056285 0.90 HTR2A (0.83) HTR2AHTR2C
SCHEMBL5055885 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL29572799 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL5052896 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL29574410 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL29572808 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL5055854 0.89 HTR2A (1.00) HTR2AHTR2C
SCHEMBL20735692 0.88 HTR2A (0.77) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019033068-A1 USE OF 5HT2A INVERSE AGONISTS FOR TREATING PSYCHOSIS AXOVANT SCIENCES GMBH (CH) 2019-02-14 WO disclosed